urothelial carcinoma
Conditions
Interventions
Gold Standard:Urine cytology
Index test:Diagnostic kit of cellular glucose metabolism (immunofluorescence techniques)
Sponsors
Junhealth Biotechnology Co. Ltd.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Group A (suspected bladder cancer patients) : (1) Meet one of the following conditions: 1) Imaging suggests space occupying in the bladder cavity; 2) Gross hematuria; 3) A history of uroepithelial cancer with high-risk recurrence factors (>=T1, G3, multiple, recurrence frequency >=1 / year); (2) Aged >=18 years, gender unlimited; (3) The patient is willing to provide a urine sample for testing; (4) The patient can provide adequate urine samples that meet the requirements of various detection methods. 2. Group B (non-bladder cancer patients) : (1) Aged >=18 years, gender unlimited; (2) The patient is willing to provide a urine sample for testing; (3) The patient can provide adequate urine samples that meet the requirements of various detection methods.
Exclusion criteria
Exclusion criteria: 1. Had undergone transurethral invasive operation within 1 month before enrollment; 2. Received therapeutic infusion chemotherapy, BCG vaccine, systemic chemotherapy, immunotherapy, etc., within 3 months before enrollment; 3. The patient had a history of other malignant tumors; 4. Poor patient compliance, unable to complete regular follow-up; 5. Sample collection and processing of samples that do not meet the requirements of standard laboratory operations and product specifications; 6. Other conditions for which the investigator judged the patient unsuitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity; | — |
Countries
China
Contacts
Public ContactJiang Haowen
Huashan Hospital Fudan University
Outcome results
None listed